David E. Lazar - Jul 26, 2023 Form 4 Insider Report for TITAN PHARMACEUTICALS INC (TTNP)

Role
Chief Executive Officer, Director
Signature
/s/ David E. Lazar
Stock symbol
TTNP
Transactions as of
Jul 26, 2023
Transactions value $
$0
Form type
4
Date filed
7/31/2023, 07:39 PM
Previous filing
Jun 28, 2023
Next filing
Jan 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TTNP Common Stock Award $0 +100K $0.00 100K Jul 26, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares reported in this transaction represent Unrestricted Stock Awards pursuant to the Issuer's Fourth Amended and Restated 2015 Omnibus Equity Incentive Plan that vested immediately on the date of grant.